We are a biopharmaceutical company engaged in the development and commercialization of patented, differentiated and premium quality cannabinoid-based nutraceuticals and pharmaceuticals.

STOCK QUOTE – CNX: BETR


 

STOCK QUOTE – OTCQB: BETRF


LATEST NEWS


 

Brands

 

Coming in Q1 2020

Our Technologies

 

BetterLife has acquired worldwide rights for four proprietary drug delivery technologies for the delivery and commercialization of cannabinoid, cannabidiol and tetrahydrocannabinol-based products

Solmic™

MICELLE ORAL DRUG DELIVERY TECHNOLOGY
FOR CANNABINOIDS

1% CBD >99% PURE
READY FOR COMMERCIALIZATON

BiPhasix™

TOPICAL DELIVERY TECHNOLOGY
FOR CANNABINOIDS

1% CBD BIPHASIX CREAM
READY FOR COMMERCIALIZATION

RTIC™

TECHNOLOGY FOR TRANFORMATION OF
CANNABIS OIL TO POWDER

READY TO INFUSE CANNABIS POWDER FOR USE IN CAPSULES, STICK PACKS, BULK POWDER, BEVERAGES, BAKED GOODS

Each technology platform allows BetterLife to produce multiple products

Investor Overview

 

Better Life Pharmaceuticals Inc. is a biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals using innovative drug delivery platform technologies. Our shares are publicly-traded on the CNX under the ticker symbol “BETR” and on the OTCQB under the ticker symbol “BETRF”

Our Leadership Team

 

BetterLife has assembled a highly experienced management team that has clinical, commercial, product development and financial experience

Email:

info@blifepharma.com

Corporate Montreal Office:

295 Kesmark, Dollard des Ormeaux
Montreal, QC, H9B 3J1, CAN

 

Contact Us

5 + 9 =